BIOCHEMICAL CONTROL RATES AND TOXICITY OF 3 REGIMENS OF HDR BRACHYTHERAPY BOOST FOR LOCALIZED PROSTATE CANCER.

被引：0
|
作者：
Gaudet, Marc [1 ]
Hamel-Perreault, Elodie [2 ]
Pharand-Charbonneau, Mathieu [1 ]
Wright, Debbie [1 ]
Haddad, Alain [3 ]
机构：
[1] CISSS Outaouais, Gatineau, PQ, Canada
[2] Univ Sherbrooke, Sherbrooke, PQ, Canada
[3] Ottawa Hosp, Ottawa, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
106
引用
收藏
页码：S40 / S41
页数：2
相关论文
共 50 条
  • [1] HDR BRACHYTHERAPY BOOST FOR LOCALIZED PROSTATE CANCER: BIOCHEMICAL:PATHOLOGY DISEASE FREE SURVIVAL AND TOXICITY REPORT
    Martin, A. G.
    Vigneault, E.
    Bachand, F.
    Harel, F.
    Beaulieu, L.
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 : S19 - +
  • [2] SINGLE FRACTION HDR BRACHYTHERAPY AS ANTICIPATED BOOST IN LOCALIZED PROSTATE CANCER
    Cerrotta, A.
    Fallai, C.
    Carrara, M.
    Borroni, M.
    Villa, S.
    Bedini, N.
    Garcia, M.
    Maucione, A.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S288 - S289
  • [3] Adverse events after HDR brachytherapy as monotherapy in localized prostate cancer.
    Kariya, S.
    Kobayashi, K.
    Yamasaki, I.
    Ashida, S.
    Inoue, K.
    Yamagami, T.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1252 - S1253
  • [4] MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life
    Maenhout, Metha
    Peters, Max
    Moerland, Marinus A.
    Meijer, Richard P.
    van den Bosch, Maurice A. A. J.
    Frank, Steven J.
    Nguyen, Paul L.
    van Vulpen, Marco
    van Zyp, Jochem R. N. van der Voort
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (03) : 554 - 560
  • [5] Long-term Experience of HDR Brachytherapy Boost for Localized Prostate Cancer
    Magnan, S.
    Despres, P.
    Martin, A.
    Foster, W.
    Aubin, S.
    Beaulieu, L.
    Vigneault, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S412 - S412
  • [6] Clinical Outcomes of 3D CRT with HDR brachytherapy in patients with localized Prostate cancer.
    Rafi, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S848 - S849
  • [7] Biochemical control and tolerance of HDR brachytherapy and 3-dimensional conformal radiotherapy for patients with clinically localized prostate cancer
    Bhatia, SK
    Yamada, J
    Cohen, GN
    Zaider, M
    Zelefsky, MJ
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S118 - S118
  • [8] Biochemical Control after HDR Prostate Brachytherapy Boost for T3b Cancer: the Stokes Centre for Urology Experience
    Metawe, M.
    Uribe-Lewis, S.
    Otter, S.
    Mikropoulos, C.
    Perna, C.
    Langley, S.
    CLINICAL ONCOLOGY, 2024, 36 (01) : E82 - E82
  • [9] HDR brachytherapy boost for prostate: Evaluation of prostate volume impact on dosimetry and toxicity
    Lavallee, M.
    Beaulieu, L.
    Despres, P.
    Martin, A. G.
    Foster, W.
    Vigneault, E.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S26 - S26
  • [10] Tomotherapy with simultaneous integrated Boost in Prostate cancer: biochemical Control rates and Late toxicity
    Geinitz, H.
    Duma, M. N.
    Nieder, C.
    Kampfer, S.
    Molls, M.
    Geier, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (02) : 178 - 178
12345